AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$BZUN

Qiu Wenbin purchased $20K of BZUN (indirect holdings)

Qiu Wenbin (Chief Executive Officer) purchased 5,800 indirectly-held shares of Baozun Inc. (BZUN) at $3.44 on 2026-10-14.

Original reporting
SEC EDGAR · Qiu Wenbin
Published Oct 16, 2026, 10:13 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 10:38 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$BZUN
Neutral
medium confidence
Mentioned
$BZUN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BZUNNeutralLow
01

Why it matters

While the transaction is small, it adds to the cumulative insider buying record for Baozun.

02

Market read

A modest insider purchase with limited immediate price impact but useful for tracking management confidence.

03

What to watch

Potential upcoming strategic initiatives not disclosed could be the real driver of the buy.

Relevance 3/10Novelty 3/10Timing: today

Background

Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$BZUNNeutralMedium confidence
Context

CEO Qiu Wenbin bought 5,800 shares for $19,952, raising his stake to 1,684,372 shares.

Expected impact

modest upward pressure as the market prices in insider confidence

Evidence & confidence

Purchase amount is under $20K, unlikely to move price alone, but insider buying is generally viewed positively.

Market effects

Sector

Limited impact on e‑commerce sector; only a small insider signal.

Regional

No broader regional effect.

Global

Minimal global relevance.

Counterpoint

What could challenge this read

The purchase could be a routine portfolio rebalancing, not a strong confidence signal.

Key entities

  • company
    Baozun Inc.

    Chinese e‑commerce solutions provider listed on NASDAQ (BZUN).

  • person
    Qiu Wenbin

    Chief Executive Officer of Baozun.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BZUN insider trading history →

Related articles

$BZUNMedAI 8/10

Baozun (BZUN) Q2 2026 Earnings Call Transcript

Baozun (BZUN) reported Q2 2026 revenue of RMB 2.7B, up 7% YoY. E-commerce revenue grew 5% to RMB 2.3B, while brand management revenue rose 22% to RMB 486M. Non-GAAP operating income increased 25% YoY to RMB 74M. The company raised its 2028 non-GAAP operating profit target to RMB 700M, citing AI-driven improvements and synergies between business segments.

yahoo.com
$BZUNHigh

Baozun Inc. (BZUN): Financial results for Q2 2026

Baozun Inc. (BZUN) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss h

SEC EDGAR 6-K
$MDGLMedAI 8/10

BAKER BROS. ADVISORS LP (BAKER FELIX, BAKER JULIAN) purchased $35.0M of MDGL (indirect holdings)

BAKER BROS. ADVISORS LP purchased 91,806 indirectly-held shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) at an average of $381.49 ($366.99–$396.61, $35.02M total) across 5 trades over 2026-11-04 to 2026-11-06. Filed jointly with Baker Bros. Advisors (GP) LLC (Director), BAKER FELIX (Director), BAKER JULIAN (Director), 667, L.P. (Director) and Baker Brothers Life Sciences LP (Director).

SEC EDGAR